Abstract:ObjectiveThe study of allergic airway inflammation turned to focus on the relationship between epithelial damage and downstream inflammatory response and became the frontier and hotspot of current research. Epithelialderived cytokine thymic stromal lymphopoietin (TSLP) is a major switch in allergic inflammatory diseases and plays an important role in the pathogenesis of allergic rhinitis. Interleukin (IL)-37, a newly discovered cytokine of the IL1 family, is a natural inhibitor of innate immunity and inflammatory responses by reducing circulating and organ cytokine levels. This article reviews the alleviation of inflammatory response of allergic rhinitis by IL37 targeting TSLP.MethodsResultsConclusion